# Haematologic Technologies, LLC dba Prolytix – FDA Inspection, May 11, 2017

Source: https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/c6e6dd3e-5093-458a-9a69-6b09b1f005a4
Source feed: FDA_Inspections

> FDA inspection 1013147 of Haematologic Technologies, LLC dba Prolytix, May 11, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013147
- Company Name: Haematologic Technologies, LLC dba Prolytix
- Inspection Date: 2017-05-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1314930 - 2026-04-17](https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/0542f691-8e6c-4a69-b14f-629cd185c8ad)
- FDA Inspection 1258523 - 2025-01-06
- FDA Inspection 1147450 - 2021-07-30
- [FDA Inspection 1098078 - 2019-06-27](https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/50ca8d3d-8097-4872-aed7-441384aec950)
- FDA Inspection 1027695 - 2017-07-28

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/edmund-f-mrak/a43cf86a-c020-4948-bff6-358b2453908a)

Company: https://www.keypedia.com/companies/haematologic-technologies-llc-dba-prolytix/03297ca5-f207-401a-8202-1b343903beed

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
